MET and breast cancer: Among them, herbacetin, which is an aglycon of herbacein glycoside, was found to significantly suppress the hepatocyte growth factor-induced motility of human breast cancer MDA-MB-231 cells by inhibiting c-Met and Akt phosphorylation, while ephedrine alkaloids did not affect this signaling pathway [56].